Two Sigma Investments
ENZN

Two Sigma Investments’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Two Sigma Investments’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-26,800
Closed -$26K – 3177
2015
Q3 		$26K Buy
+26,800
New +$33K ﹤0.01% 2112
2015
Q1 		– Sell
-119,599
Closed -$130K – 3058
2014
Q4 		$130K Sell
119,599
-39,215
-25% -$41.2K ﹤0.01% 2115
2014
Q3 		$172K Buy
158,814
+24,078
+18% +$29.7K ﹤0.01% 1621
2014
Q2 		$140K Sell
134,736
-32,452
-19% -$30.9K ﹤0.01% 2024
2014
Q1 		$173K Sell
167,188
-21,075
-11% -$21.8K ﹤0.01% 1836
2013
Q4 		$218K Buy
188,263
+106,531
+130% +$164K ﹤0.01% 1985
2013
Q3 		$137K Sell
81,732
-64,532
-44% -$119K ﹤0.01% 1716
2013
Q2 		$292K Buy
+146,264
New +$428K ﹤0.01% 1646

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Two Sigma Investments's ENZN Position: Q4 2015 in Review

Two Sigma Investments sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2015, closing a stake of 26,800 shares — an estimated $26K sold.

Two Sigma Investments first reported a position in ENZN in Q2 2013 and held it in 8 quarters. The position peaked at $292K in Q2 2013. 49 funds tracked by Wall St. Rank hold ENZN as of Q4 2015.

  • Two Sigma Investments reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2015 after selling out during the quarter.
  • Two Sigma Investments sold 26,800 ENZON PHARMACEUTICALS INC shares in Q4 2015, an estimated $26K.
  • Two Sigma Investments first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 8 quarters.
  • Two Sigma Investments's ENZON PHARMACEUTICALS INC position peaked at $292K in Q2 2013.
  • 49 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2015.

Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.